age
Item
subject must be at leat 18 years of age
boolean
C0001779 (UMLS CUI [1])
informed consent
Item
subject is able to verbally confirm understandings of risks, benefits and treatment alternatives of cilostazol and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.
boolean
C0021430 (UMLS CUI [1])
Coronary Stenosis Percentage Visual estimation
Item
subject must have significant coronary artery stenosis (>50% by visual estimate)
boolean
C0242231 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0444684 (UMLS CUI [1,3])
Myocardial Ischemia; Stable angina; Angina, Unstable; History of myocardial infarction; Silent myocardial ischemia; ECG signs of myocardial ischaemia; Coronary Stenosis
Item
subject must have evidence of myocardial ischemia (e.g., stable, unstable angina, recent infarction, silent ischemia, positive functional study or reversible changes in the electrocardiogram (ecg) consistent with ischemia. in subjects with coronary artery stenosis>75%, evidence of myocardial ischemia does not have to be documented.
boolean
C0151744 (UMLS CUI [1,1])
C0340288 (UMLS CUI [1,2])
C0002965 (UMLS CUI [1,3])
C1275835 (UMLS CUI [1,4])
C0340291 (UMLS CUI [1,5])
C1141959 (UMLS CUI [1,6])
C0242231 (UMLS CUI [1,7])
coronary stenosis amenable for percutaneous coronary revascularization with drug eluting stents
Item
coronary lesions must be amenable for percutaneous coronary revascularization with drug eluting stents.
boolean
C0242231 (UMLS CUI [1,1])
C3526701 (UMLS CUI [1,2])
C1262327 (UMLS CUI [1,3])
Emergency percutaneous coronary intervention; Acute ST segment elevation myocardial infarction
Item
subject who undergoes primary percutaneous coronary intervention due to acute st elevation myocardial infarction
boolean
C1532297 (UMLS CUI [1,1])
C1303258 (UMLS CUI [1,2])
hypersensitivity or contraindication to anti-platelet agents (aspirin, clopidogrel or cilostazol)
Item
subject who has contraindication or allergy to anti-platelet agents (aspirin, clopidogrel or cilostazol)
boolean
C0020517 (UMLS CUI [1,1])
C1301624 (UMLS CUI [1,2])
C2963157 (UMLS CUI [1,3])
C0020517 (UMLS CUI [2,1])
C0004057 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0070166 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0055729 (UMLS CUI [4,2])
platelet count measurement
Item
subject who has thrombocytopenia (<120,000/ul)
boolean
C0032181 (UMLS CUI [1])
liver cirrhosis
Item
subject who has liver cirrhosis (child class b or c)
boolean
C0023890 (UMLS CUI [1])
anticoagulation
Item
subject who is on the anticoagulation therapy
boolean
C0449867 (UMLS CUI [1])
congestive heart failure, left ventricular ejection fraction
Item
subject who has severe congestive heart failure (left ventricular ejection fraction <30%)
boolean
C0018802 (UMLS CUI [1,1])
C0428772 (UMLS CUI [1,2])